Arthur T. Porter appointed to LMS Board of Directors
January 16 2006 - 8:30AM
PR Newswire (US)
MONTREAL, Jan. 16 /PRNewswire-FirstCall/ -- LMS Medical Systems
(AMEX:LMZ; TSX:LMZ), a healthcare technology company and developer
of the CALM(TM) system (Computer Assisted Labor Management),
announced today the appointment of Dr Arthur T. Porter, MA, MD,
MBA, DMRT, FRCPC, FACR, FACRO, FAAMA, as a member of its Board of
Directors. Dr Porter is Director General and CEO of the McGill
University Health Centre (MUHC), Montreal, Canada. The MUHC is one
of the most comprehensive academic health centers in North America
comprising five teaching hospitals, over 1,300 clinicians and some
13,000 health care professionals, researchers and personnel. In
September 2005, the Minister of Health of Quebec appointed Dr
Porter as President of the McGill Integrated University Health
Network, a health delivery network serving 1.6 million people. Dr
Porter's extensive international health background includes medical
practice in radiation oncology, business and academic leadership
positions in Canada, Europe, Africa and the United States. He also
served as a consultant to the World Health Organization and has
worked to establish international medical research and treatment
programs in a number of countries. From 1999 to 2004, Dr Porter
held the position of CEO of the Detroit Medical Center, a US$1.6
billion health system in one of the United States' largest urban
areas. In addition, Dr Porter is on the Editorial Board of 13
scientific journals and has to his credit numerous scholarly works
in peer- reviewed journals, chapters in books and in proceedings of
conferences. In September 2001, U.S. President George W. Bush
appointed Dr. Porter to the Presidential commission charged with
reviewing the health care provided by the Department of Defense and
the Veterans' Administration. Dr Porter is, amongst others, a
member of the Board of Directors and the Audit Committee of the
Munder Funds, as well as a board member of Adherex, a publicly
traded biotechnology company, and chairs its Compensation
Committee. "Dr Porter's approach to accelerate the introduction of
innovation in healthcare, from "bench to bed", is stimulating for
LMS, our Company being a direct product of McGill University
research," said Mr. Benoit LaSalle, Chairman of the Board of LMS.
"He represents a valuable addition to the board at a time when the
Company is poised to re-engineer various aspects of medical
practice in obstetrics." About LMS: LMS Medical Systems is a leader
in the application of advanced mathematical modeling and neural
networks for medical use. The LMS Computer Assisted Labor
Management product suite provides physicians, nursing staff and
risk managers with innovative obstetrical decision support and risk
management tools integrated into robust clinical information
systems designed to improve outcomes and patient care for mothers
and their infants during labor and delivery. This press release
contains forward-looking statements that involve risks and
uncertainties, which may cause actual results to differ materially
from the statements made. For this purpose, any statements that are
contained herein that are not statements of historical fact may be
deemed to be forward- looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Without limiting the foregoing, the words "believes,"
"anticipates," "plans," "intends," "will," "should," "expects,"
"projects," and similar expressions are intended to identify
forward-looking statements. You are cautioned that such statements
are subject to a multitude of risks and uncertainties that could
cause actual results, future circumstances, or events to differ
materially from those projected in the forward-looking statements.
These risks include, but are not limited to, those associated with
the success of research and development programs, the adequacy,
timing, and results of clinical trials, the regulatory approval
process, competition, securing and maintaining corporate alliances,
market acceptance of the Company's products, the strength of
intellectual property, financing capability, the potential dilutive
effects of any financing, reliance on subcontractors and key
personnel, and other risks detailed from time-to-time in the
Company's public disclosure documents or other filings with the
Canadian and U.S. securities commissions or other securities
regulatory bodies. The forward-looking statements are made as of
the date hereof, and the Company disclaims any intention and has no
obligation or responsibility, except as required by law, to update
or revise any forward- looking statements, whether as a result of
new information, future events, or otherwise. DATASOURCE: LMS
MEDICAL SYSTEMS INC. CONTACT: Andrea Miller, Communications, LMS
Medical Systems Inc., (514) 488-3461 Ext. 222, Fax: (514) 488-1880,
, Website: http://www.lmsmedical.com/
Copyright